About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
Congress passed the Bayh-Dole Act in 1980 to incentivize the private sector to make the investments needed to translate discoveries (i.e., inventions) arising from government-funded research into useful commercial products. Specifically, it allows grant recipients, such as universities, to hold the title to the patents covering such discoveries, enabling them to license the patents and right to use those discoveries to private sector partners who can then commercialize them.
The Success of Bayh-Dole image
Resource
Intellectual Property
The Success of Bayh-Dole
The Success of Bayh-Dole image